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Women diagnosed with breast cancer younger than 45 years (young breast cancer survivors – 
YBCS) and their biological relatives face significant stressors. Although family support is an 
important coping resource, little is known about YBCS’ and relatives’ support and whether it is 
interdependent. The study described family support in YBCS and their biological relatives; 
identified demographic, clinical and psychosocial predictors of support; and determined the 
interdependence of support in YBCS-relatives family units.  
Methods 
Data were collected from a random sample of YBCS and their first-or-second-degree female 
relatives. Actor-Partner- Interdependence-Models (APIM) explored predictors and 
interdependence of YBCS’ and relatives’ family support in dyads (YBCS and relative) and triads 
(YBCS and two relatives).  
Results 
Among n=310 YBCS and n=431 first-or-second-degree relatives, family support was higher in 
triads compared to dyads. APIMs identified actor effects in dyads, and actor and partner effects 
in triads. Across all family units, YBCS’ higher self-efficacy was associated with higher YBCS 
support (actor effect) and relative support (partner effect); YBCS’ prior diagnosis of depression 
was associated with lower YBCS and relative support (actor and partner effect); cost-related 
lack of access to care was associated with lower support among YBCS (actor effect) and 
relatives (actor and partner effect). 
Conclusions 
Family support was interdependent and was affected by self-efficacy, depression, and access to 
care. Interventions should include YBCS and relatives; enhance self-efficacy and access to care. 
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Background 
Breast cancer is the most prevalent female cancer worldwide, with 1.38 million new cases 
annually1. About 25% of all breast cancer cases are diagnosed in women under 50 years old, 
constituting a growing clinical population of younger women with breast cancer2. Early onset 
breast cancer presents several challenges, including tumors that are more aggressive, higher 
recurrence rates, and increased mortality, and is associated with genetic predisposition. Fir t- 
and second-degree relatives of young breast cancer survivors (YBCS) have a 2.3 and 1.5 
increased relative risk for breast cancer, respectively3.  
 
YBCS often report poorer outcomes compared to their older counterparts due to different 
stressors and social roles4, 5. YBCS caring for young children may face additional difficulties 
communicating concerns, and may feel responsible for transmitting an increased cancer risk to 
their offspring4, 5. Caring for children and older parents, combined with the challenges of the 
disease can cause additional distress, anxiety, depression, fear of recurrence, and difficulties 
returning to work4, 6, 7. Loss of income due to inability to work can lead to additional financial 
stressors and lack of access to care 5. Thus, YBCS may need significantly more support to 
overcome these challenges compared to older breast cancer patients 8.  
 
Although biological female relatives have an elevated risk for breast cancer, they may not 
always cope with this risk and manage it effectively. Young women with a strong family 
history may have heightened perceptions of breast cancer risk, chronic depression, anxiety, 
and increased breast cancer worry9-11. Family members are an important source of 
information about risk factors, genetics, and available screening and risk-reducing strategies, 
especially for women from medically underserved communities12.  Multiple family members 
are likely to be involved, directly or indirectly, in appraisals regarding the magnitude of the 
health threat and the availability of coping resources. However, family members may 
perceive different levels of vulnerability and stigmatization associated with hereditary breast 
cancer, experience different levels of distress, and disagree about the extent of family 
involvement needed to reduce these stressors13-15. Input from different family members 
affects support they are willing to give and receive to each other.   
 
There is a need to promote longterm coping in YBCS and relatives and to mitigate the burden 
of early onset breast cancer4, 5. Family support is essential to successful coping of breast 
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relationships usually influence each other’s thoughts, emotions, and coping behaviors18. Yet, 
little is known about a possible interdependence of family support in YBCS and biological 
relatives, who also face an increased breast cancer risk due to heredity. The study addressed 
this gap in the literature. Specific aims were to describe family support in YBCS and their 
relatives; identify demographic, clinical and psychosocial characteristics as predictors of 
family support; and determine the interdependence of support in YBCS-relatives family units.  
 
Theoretical Framework 
The study was guided by the integration of the theory of stress and coping19 with the theory 
of family systems in genetic illness20 applied to families with hereditary breast cancer risk21. 
Stress occurs when primary appraisals of a health problem threaten one’s well-being19. 
Primary appraisals include YBCS’ and relatives’ assessment of stressors associated with early 
onset breast cancer, e.g., cost of healthcare. Primary appraisals may interfere with the ability to 
withstand stress because they can exacerbate YBCS’ depression and fear of cancer recurrence, 
and increase relatives’ perceived breast cancer risk22, 23. Initial appraisals are followed by 
appraisals about the availability of personal (e.g., self-efficacy for managing breast cancer23) and 
social coping resources (e.g., family support) that can help manage the health threat. Family 
support is the primary outcome of the study in both YBCS and their relatives. (Figure 1). 
Methods 
Design, Setting, and Sample 
The study used baseline data obtained with a self-administered survey for an e ficacy trial 
designed to increase surveillance and use of cancer gen tic services in YBCS and their first- and 
second-degree relatives (ClinicalTrial.gov ID:NCT01612338)24. Al l Institutional Review 
Boards involved in the identification, recruitment, and consent of participants approved the 
study protocol. Methodological and recruitment details have been reported24, 25.  A random 
sample of 3,000 YBCS was selected from the Michigan Cancer Surveillance Program 
(MCSP). Age criteria for YBCS varies among studies from 40-50 years old and under; we 
were conservative in our sample selection and we chose a cut off of 45 years or younger at 
the time of diagnosis. The sample was stratified by race (1,500 Black versus 1,500 
White/Other YBCS) to ensure an adequate representation of Black YBCS. The “Other” 
category includes about 7% of Michigan YBCS not recorded in the registry as Black or 
White (e.g., Arab American, etc.). Due to their small numbers, YBCS of other racial/ethnic 
backgrounds could not form a separate stratum. YBCS were eligible to participate if  they 
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younger than 45 years old at the time of diagnosis and younger than 65 years old at the time 
of the study; and were willing to invite one or two relatives in the study. Relatives had to be 
female and in first- or second-degree biological relationship with the YBCS. They had to be 
younger than 65 years old, and cancer-free at the time of the study.  
 
Prior to contacting the YBCS, the director of the MCSP inquired with the reporting facility and 
physician of record whether there was any reason that the YBCS could not participate in the 
study. If MCSP did not receive a negative response within 30 days, an invitation letter 
explaining the study, a consent form, a self-administered baseline survey, and a stamped return 
envelope were mailed to YBCS. Eligible YBCS received up to three mailed invitations to 
participate in the study. In order to have family units with comparable size, the study invited up 
to two relatives per YBCS. There were 58 YBCS carrying a mutation associated with hereditary 
breast cancer who were excluded from this paper; thi  relatives were not invited in the efficacy 
trial since the focus was to increase use of genetic s rvices among untested families. 
 
Instruments 
The study outcome was family support in YBCS and relatives. According to the theoretical 
framework predictors included stressors for YBCS (lack of access to care due to cost, 
anxiety, depression, and fear of cancer recurrence) and for relatives (perceived breast cancer 
risk), resources for YBCS (self-efficacy dealing with breast cancer), and demographic 
characteristics for both YBCS and relatives. 
 
Family support was conceptualized as open communication, support in times of illness, and 
coherence, and was measured with three well-established scales. All items were rated on a 
seven-point Likert scale, ranging from one “Strongly Disagree” to seven “Strongly Agree.” 
Family communication was assessed with the Lewis Mutuality and Interpersonal Sensitivity 
Scale (MIS)26, validated with breast cancer survivors and their family members27, 28. MIS 
includes 15 items (e.g., “The people in my family change the topic when I discus  my 
concerns”); internal consistency in this study was 0.94. Family support in times of illness 
was assessed with the Family Support in Illness scale, originally developed for women 
pursuing breast cancer screening29. The scale includes 10 items (e.g., “In our family, when I 
have a health problem, there is someone helping me get the care that I need”); internal 
consistency in this study was 0.91. Family coherence is the ability of the family to cope with 
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cancer and non-cancer patients 31, 32. FHI includes 20 items (e.g., “In our family we have a 
sense of being strong even when we face big problems”); internal consistency was 0.90.  
 
A family support index was created from these three scales. Principal Component A alysis 
(PCA) examined the correlations of items (n=45). The Kaiser-Meyer-Olkin measure of 
sampling adequacy and the Bartlett's test of sphericity indicated that PCA was possible. 
PCA identified a primary component of family support. Pearson correlation coefficients in 
the component matrices ranged between 0.40-0.80. Four items did not correlate adequately 
with the principal component and were not used. An overall family support index was 
created by calculating a mean score from the three scales as the dependent variable. 
 
Stressors  
Cost-Related Lack of Access to Care was assessed with one item asking YBCS and 
relatives “Has there been a time within the past 12 months that you needed to see a doctor 
or have a medical test but you could not because of high out-of-pocket cost?” yes/no; yes, 
indicates cost-related lack of access to care. 
Anxiety and Depression were assessed with two items asking YBCS and relatives “Have you 
ever been told by a healthcare provider that you have anxiety?” yes/no and “Have you ever 
been told by a health care provider that you have depression?” yes/no. These variables were 
assessed because they interfere with support and communication33, 34, a d better family 
functioning mitigates depressive symptoms among cancer patients35. 
Fear of Cancer Recurrence (YBCS only) was assessed with four items from the Concerns 
About Recurrence Scale (CARS) (e.g., “How much time do you spend thinking about your 
breast cancer coming back”) using a seven-point Likert scale from one “Not at all” to seven 
“All the time”36. Internal consistency was 0.91. 
Perceived Breast Cancer Risk was assessed with one item asking YBCS and relatives to rate 
their chances of (another) getting breast cancer on a 10-point Likert scale with verbal anchors 
“Definitely will not” to “Definitely will”37.  
Resources 
Self-efficacy – Breast Cancer. Self-efficacy managing breast cancer (YBCS only) was 
assessed with 14 items (e.g., “Since my breast cancer diagnosis, I am able to do the things that 
are important for me”) scored on a seven-point Likert scale, ranging from one “Strongly 
Disagree” to seven “Strongly Agree”38. Internal consistency was 0.95. 
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relative being first- vs. second degree, years since diagnosis, number of cancer diagnoses etc. 
were assessed in YBCS and relatives with items fromthe Behavioral Risk Factors Surveillance 




Analyses were performed with SPSS® version 22.041 and MPlus version 7.042. Sample 
characteristics, stressors, and resources, were described with means, standard deviations 
(SD), frequencies (n), or percentages (%), depending on scaling and data distribution. A p 
value ˂ 0.05 was considered statistically significant i  all analyses. Demographics and 
clinical characteristics were included in all models as covariates. 
 
Data from dyads and triads often violate the fundamental assumption of many data analyses 
methods, that data are collected from independent subjects. YBCS and relatives have an 
existing interpersonal relationship, thus, correlations between YBCS’ and relatives’ data 
need to be taken into account. The Actor-Partner-Interdependence Model (APIM) has been 
used to study complex dynamics in families and close relationships43. It assesses 
interdependence and bidirectional effects within interpersonal relationships44. Observation 
interdependence necessitates examining the dyad (i.e., the pair) as a single unit of analyses, 
rather than two units (i.e., as single individuals). Interdependence means that observations from 
two or more individuals are linked. Knowledge of one’s characteristics (actor) can provide 
information about the other person’s (partner) attitudes, etc. Assessing bi-directionality involves 
examining each person’s influence on the other person’s outcomes.     
 
We identified three types of family units for this study: da s consisting of one YBCS and one 
relative; triads consisting of one YBCS and two relatives; and YBCS with no eligible relatives 
or whose relatives did not accept participation. The latter group was excluded from APIM 
analyses and this paper. APIM examined predictors of family support in dyads and triads. A 
dyadic model captured the interdependence of family support between YBCS and one relative 
(Figure 2a), and a triadic model among YBCS and two relatives (Figure 2b). Actor effects are 
observed when characteristics of one person (e.g., their own resources) are significant predictors 
of their own outcome (i.e., family support), regardless of whether this is an YBCS or a relative.  
Partner effects refer to cross-dyadic or cross-triadic ssociations, and are observed when 
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We examined evidence of non-independence i  the outcome variable (family support index) 
by assessing the level of intra-class correlations18, 43. Intra-class correlations in dyads and 
triads was statistically significant (0.31, 95%CI 0.17-0.43, ANOVA F=1.88, p<0.001; and 
0.37, 95%CI 0.23-0.50, ANOVA F=2.16, p<0.001, respectively), suggesting 
interdependence of support in family units, and that analyses should follow a dyadic and 
triadic format. Data were restructured in dyads including one YBCS and one relative and 
triads including one YBCS and two relatives. Mixed predictor variables (variables that 
exhibit both between- and within-dyad/triad variability) were used to estimate the 
interdependence effects of family support18, 43, 44. Full information on maximum likelihood 
estimation (FIML) was used in path analyses. FIML produces unbiased estimates based on 
all available information from variables included in an analysis, when data are missing at 
random (MAR) or missing completely at random (MCAR).    
 
A fundamental tenet of dyadic analyses is determining d stinguishability, meaning, whether or 
not there is a way to treat each individual as different18.  Distinguishable dyads are, for example, 
heterosexual couples; indistinguishable dyads are, for xample, same-sex roommates. Wecould 
distinguish members of dyads (YBCS and relatives), but we were unable to distinguish the two 
female relatives included in triads.  The two relatives in triads were treated as indistinguishable, 
because there were no specific criteria that could designate one relative as a primary participant 
and the other relative as a secondary participant. Consequently, we used a novel approach for 
triadic analyses based on analyses methods of indistinguishable dyads. In indistinguishable 
dyads, data from the two individuals are pooled in order to produce parameter estimates 18, 45, 46. 
Following this approach, in the triadic APIM we pooled the estimates from the two relatives into 
one estimate by imposing equality constraints. Pooling the estimates from two indistinguishable 
relatives allowed us to estimate the effects from the two relatives as a single “relative” effect.  
 
Indicators of adequate model fit in triadic APIM were a comparative fit index (CFI) above 
0.90, a non-significant chi-square statistic or a ratio of chi-square statistic to degrees of 
freedom (df) less than two, a root mean squared error of approximation (RMSEA) value of 
0.08 or less, and a standardized root mean square residual (SRMR) value of 0.08 or less47, 48. 
We tested both an unconstrained dyadic model (fully saturated) and a constrained dyadic 
model (with actor=actor and partner=partner) constraints49. A significant difference between 
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From the 3,000 identified YBCS, n=883 accepted participation (response rate 33.2% after 
excluding deceased, missing current address etc.). From these 883 YBCS, n=573 participated 
in the study alone, either because they had no eligible relatives, or because their relatives did 
not accept study participation25. To address APIM analyses, in this paper we include only 
those YBCS, n=310, who participated in the study with one or two relatives.  
 
The 310 YBCS and their 431 blood female relatives constituted 189 dyads (one YBCS and one 
relative) and121 triads (one YBCS and two relatives). Most family units (n=249) included only 
first-degree relatives (n=164 dyads; n=85 triads); 32 family units included only second-degree 
relatives (n=25 dyads; n=7 triads); 29 triads were mixed, with both first- and second-degree 
relatives. YBCS were on average 51 years old at the time of the study and 11 years post 
diagnosis; approximately one in five (19.7%) had more than one cancer diagnoses. Most 
YBCS were White/Other, had an annual household income less than $80,000, had some 
college-level education or above, and were married.  Relatives were on average 43 years old; 
most were White/Other, had an annual household income less than $60,000, had some college-
level education or above, and were married. (Table 1). 
 
Participants reported high levels of family support on the thr e family support scales (i.e., 
communication, support in illness, and coherence) (observed range: 5.4-6.1) and the family 
support index (YBCS: 5.6±0.9; relatives: 5.7±0.9) (Table 2).  Relatives reported significantly 
higher family communication compared to YBCS. White/Other participants (YBCS and 
relatives combined) reported a higher score on the Family Support in Illness scale compared 
to Black participants (6.0±1.1 vs. 5.8±1.2, p=0.001); this difference was not observed in the 
other two scales. Family support in illness was also higher in triads than dyads (Table 3).  
Predictors of family support in dyads and triads - APIM 
Dyadic findings: APIM with 189 dyads (YBCS and one relative) identified significant actor 
effects in YBCS and relatives, but no partner effects (Table 4). First, we tested an 
unconstrained dyadic model, which allowed actor and partner effects to differ between YBCS 
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without fit indices, we tested an additional model where we constrained the actor effects to be 
equal to each other and the partner effects also to be equal to each other. No constraints were 
placed on dyad-level predictors, i.e., years since diagnosis, race, and degree type; on variables 
measured only in YBCS, i.e., fear of recurrence and self-efficacy. Chi-square difference tests 
revealed that the effects did not differ across YBCS and relatives in the dyadic model 
(Χ2diff=15.390, df=18, p=.6350). Thus, we report the constrained model results in Table 4. 
Similarly to the unconstrained model, only actor effects were significant; a prior diagnosis of 
depression and cost-related lack of access to care were associated with lower family support 
for YBCS and relatives. The strength of the actor effects between depression and cost-related 
lack of access to care did not differ between YBCS and relatives. More years since diagnosis 
and higher self-efficacy were associated with higher family support for YBCS, whereas Black 
race was associated with higher family support in relatives.  
Triadic findings: With the exception of the CFI (.616), model fit indices were acceptable in the 
APIM triad analyses (non-significant chi-square, p=.0552; X2/df ratio = 1.18; RMSEA = .038; 
SRMR =.057). APIM with 121 triads (YBCS and two relatives) identified significant actor 
and partner effects (Table 4). YBCS’ self-efficacy was associated with higher YBCS family 
support. YBCS’ cost-related lack of access to care and more years since diagnosis were 
associated with lower YBCS family support. Black race in relatives was associated with 
higher relative family support, while relatives’ cost-related lack of access to care was 
associated with relatives’ lower family support. Four partner effects were identified in triads. 
YBCS’ prior diagnosis of depression was associated with relatives’ lower family support; 
YBCS’ older age and higher self-efficacy were associated with relatives’ higher support; and 
relatives’ higher income was associated with YBCS’ higher support.  
 
Discussion 
Early onset breast cancer can have a profound impact on cancer patients and their families. 
YBCS are a special group who have to manage both their own disease and their family roles. 
Their biological relatives also have to realize, accept, and manage a higher breast cancer risk. 
Family support is a valuable resource that can help address these challenges.  
 
Family support in YBCS and Relatives  
Relatives reported higher family communication compared to YBCS, possibly due to YBCS’ 
unmet communication needs, especially for illness-rlated issues 50, 51. White/Other participants 
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to Black participants. This could be partly because Black YBCS were significantly more likely 
to invite relatives living further than 50 miles awy to participate in the study with them (data 
shown elsewhere)25, which could affect tangible support offered and received at times of illness. 
Triads reported higher family support at times of illness compared to dyads, presumably 
because it can be more difficult to find support from others at that ime. Participating in the 
study with two versus one relatives may indicate a stronger and larger support network. 
 
Predictors and interdependence of family support  
APIM examined both actor and partner effects, with the former being primary predictors of 
family support. Partner effects were observed only in triads, possibly due to greater chances of 
one person affecting the other person’s responses.  
Self-efficacy. Consistent with other studies, YBCS’ breast cancer self-efficacy was an important 
predictor of their own family support (actor effect)52, 53. In dyads and triads, YBCS with more 
confidence in their ability to manage demands associated with breast cancer reported higher 
family support. Self-efficacy is a key resource for cancer survivors associated with important 
outcomes, such as better mental health54 nd higher quality of life55. A novel finding of our study 
was that YBCS’ higher self-efficacy had a significant partner effect on relatives’ perceived 
family support in triads. Relatives may find it easi r to help YBCS who have higher self-
efficacy and fewer needs, as it may be less burdensome. YBCS who are better able to manage 
disease-related stressors by themselves, may feel mor  self-reliant, creating less strains and 
demands on their family. YBCS with lower self-efficacy is a group at risk for adverse outcomes 
and warrants further assessment and early intervention. In contrast, YBCS with higher self-
efficacy could be a resource for their relatives, who may also benefit from support in managing 
their own anxiety about cancer risk. This reciprocal rel tionship merits more investigation. 
Cost and access to care. About one in five YBCS and one in five relatives reported that 
there was a time during the past 12 months that they needed medical care but could not get it 
due to high out-of-pocket costs. Higher income is usually associated with availability of 
expendable resources to address illness-related expenses7, 56. Cancer may cause significant 
financial burdens and high out-of-pocket costs for YBCS; lack of support and available 
resources at times of need may further deter YBCS from accessing care. Relatives with 
higher income had a positive partner effect on YBCS’ family support in triads, possibly because 
they are considered an actual or potential resource to YBCS, accounting for YBCS 
perceiving higher support from them. 
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effect). Depression during diagnosis and treatment worsens for some breast cancer patients, 
especially for those lacking a partner or other forms of support57, 58. Relatives who reported 
lower family support were also more likely to report a prior diagnosis of depression (actor 
effect in dyadic relationships), or to be associated with an YBCS with depression (partner effect 
in triadic relationships). The partner effects of YBCS’ prior diagnosis of depression indicate 
that YBCS’s depressive symptoms may influence relatives’ perceived family support. 
Relatives are expected to provide support to cancer survivors, although they also experience 
stressors and need support59; when relatives are depressed, they may perceive rceiving less 
support, possibly as appreciation for their efforts60. In a prior APIM analyses with a different 
sample of cancer survivors and their family caregivers, we also identified significant 
longitudinal partner effects between cancer patients’ depression and their family 
caregivers61. Helping YBCS and relatives identify and manage depression is an important 
intervention area. However, we acknowledge that our findings may be influenced by 
participants’ recall bias, since we measured anxiety and depression with single-item 
questions asking participants to recall what was told to them.  
Race. The activation of family support, which often increases with the burden of illness, can 
strengthen family relationships but can also strain network ties. In the face of a cancer diagnosis, 
family resources may be more readily available for some YBCS, or conversely not available for 
others, bringing up any differences in perceived family support that may have existed pre-
diagnosis. Relatives of Black YBCS may hold strong beliefs about their familial obligations, 
due to strong familial and community orientations62. Expressions of familialism and 
collectivism are more evident in Blacks than other racial groups, due to a traditional 
caregiving ideology, related to collectivism in social relationships63. However, this finding 
should be interpreted with caution, since there was a smaller number of Black relatives in 
the study and the other group included White YBCS and a small proportion of YBCS of 
other ethnic/racial background.  
Length of survivorship. Finally, being a longer-term cancer survivor was as ociated with less 
family support reported by YBCS in triadic relationships. Since YBCS in the study were 
diagnosed on average 11 years prior, family members may assume that YBCS need less support 
over time. This may not necessarily be accurate, as some YBCS may have to cope with late 
effects of cancer treatment or pervasive fear of cancer recurrence64, 65. YBCS’ age had a positive 
partner effect on relatives’ family support, presumably because some longer-term cancer 
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Strengths and Limitations  
Limitations include self-reporting and recruitment preferences. Relatives were invited directly 
from YBCS, which assumes that relatives in good relationship with the YBCS were 
prioritized; this may explain the small range of scores in the family support index (5.3-6.1; 
possible range 1-7). The study invited up to two relatives per YBCS for comparable family 
units, although, some YBCS may be receiving support from larger networks. Stressors i.e., 
anxiety and depression were assessed with single item measures instead of lengthier instruments 
to reduce overall burden, but responses may be influe ced by recall bias. YBCS of “other” 
racial/ethnic backgrounds were combined with White YBCS, thus, findings related to race may 
cannot be generalized. Finally, we did not assess whether YBCS were receiving treatment, 
which may have implications for family support they needed at the time of the survey.  
 
Future research with YBCS and relative triads, may consider a conceptually meaningful way 
to distinguish relatives as part of the study design and in line with the study aims. For 
example, the study could have required YBCS to designate one relative who provides more 
support. However, prior work of the research team demonstrated that cancer patients have 
difficulty and may feel uncomfortable about making a choice and indicating who provides 
more support. Thus, we consider that extending the “family” beyond two people and attending 
to the challenges of more complex analyses as significant strengths of our study. 
 
We examined self-efficacy as a predictor of family support, which is not the way it has been 
traditionally examined in prior literature. Our findings indicate a strong correlation between 
family support and patients’ self-efficacy (i.e., patients’ confidence in their own ability to 
manage the disease). Traditionally, family support has been examined as a predictor of self-
efficacy. An alternative hypothesis suggests that the ability of people to provide support is 
associated with the characteristics of the person needing support. It may be more difficult to 
support cancer patients who have low self-efficacy (i.e., low self-confidence) in their ability to 
manage the disease. It is possible that the support person may need to spend more time 
bolstering or encouraging the patient with low self-efficacy, which may become burdensome 
over time. Further research is needed in this area. Due to the cross sectional nature of the data, 
we can only report the significant correlation between self-efficacy and support rather than 
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Family support enhances the long-term physical and mental well-being of cancer patients and 
their family members6, 16, 67-69. It also provides greater cohesion and strengthens the 
interpersonal contacts among breast cancer patients and their relatives67. Our findings 
demonstrate the interdependence of family support between YBCS and their close biological 
relatives. APIM provided valuable insights into complex family relationships taking also into 
account relatives’ increased breast cancer risk due to possible hereditary susceptibility. 
Consistent with our theoretical framework, self-efficacy and access to care were important 
resources that influence family support. Perceived stressors associated with early onset breast 
cancer and availability of resources may affect the level of support family members are willing to 
give and receive to each other. Due to the interdependence among YBCS and their relatives, 
supportive programs need to focus on the YBCS-relativ  s the unit of care, and include family-
based interventions that enhance each person’s self-efficacy and access to high quality services70-72. 
Existing evidence-based interventions for cancer patients and their family caregivers72-75 could be 
adapted to address the needs of YBCS and their relat ves. It is also important for researchers and 
clinicians to work together and develop technology-based dyadic interventions that are cost 
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Demographics    
Age (mean ± SD†) 51.4±5.8 43.4±11.9 p<0.001 
Race (N, %‡)    
White/Other 242 (78.1 %) 344 (79.8 %)  
Black 68 (21.9 %) 87 (20.2 %) p=0.629 
Education (N, %‡)    
Elementary school only 0 (0 %) 2 (0.5 %)  
High school (Grades 9-11) 2 (0.7 %) 9 (2.1 %)  
Compulsory education (K-12) 56 (18.3 %) 61 (14.4 %)  
Some college 113 (36.9 %) 157 (37.0 %)  
Completed college 74 (24.2 %) 126 (29.7 %)  
Postgraduate  degree 61 (19.9 %) 69 (16.3 %) p=0.109 
Employment (N, %‡)    
Full time 157 (50.7 %) 237 (57 %)  
Part-time 42 (13.5 %) 64 (15.4 %)  
     Unemployed/Other§ 111 (35.8 %) 115 (27.6 %) p=0.357 
Income (N, %
‡
)    
<$20,000 24 (8.7 %) 51 (13.2 %)  
$20,000-$39,999 42 (15.2 %) 84 (21.8 %)  
$40,000-$59,999 50 (18.1 %) 68 (17.6 %)  
$60,000-$79,999 51 (18.4 %) 53 (13.7 %)  
$80,000-$99,999 30 (10.8 %) 36 (9.3 %)  
$100,000-$119,999 29 (10.4 %) 33 (8.5 %)  
>$120,000 51 (18.4 %) 61 (15.8 %) p=0.103 
Marital status (N, %‡)    
Married/Life  partner 212 (68.4 %) 257 (59.8 %)  
Single/Divorced/Widowed 98 (31.6 %) 173 (40.2 %) p=0.020 
Lives alone 44 (14.2 %) 60 (13.9 %) p=0.998 
Clinical characteristics    
Years since 1st diagnosis (mean ± SD†) 11.6 ± 4.0 N/A¶  




























Depression (N, %‡) 84 (27.5 %) 111 (26.1%) p=0.731 
Stressors    
Cost-related lack of access to care (N, %‡) 56 (18.1 %) 82 (19.2 %) p=0.779 
Fear of cancer recurrence (mean ± SD†) 3.4 ± 1.6 N/A¶  
Perceived breast cancer risk (mean ± SD†) N/A¶ 4.7 ± 2.0  
Resources    
Self-efficacy (mean ± SD†) 5.9 ± 1.1 N/A¶  
† Standard Deviation;  ‡ Valid percentages; §Student, retired, housewife;  
¶ N/A: Not applicable 
 
Table 2. Family Support in YBCS and Relatives 
 
 
 YBCS (N=310) 
Mean ± SD† 
Relatives (N=431) 
Mean ± SD† 
p value 
Family Communication 5.4 ± 1.1 5.6 ± 1.1 0.040 
Family Support in Illness 6.0 ± 1.1 6.1 ± 1.0 0.087 
Family Coherence 5.4 ± 0.8 5.5 ± 0.8 0.688 
Family Support Index 5.6 ± 0.9 5.7 ± 0.9 0.112 
† Standard Deviation 
 








Family Communication 5.4 ± 1.2 5.6 ± 1.0 0.437 
Family Support in Illness 6.0 ± 1.1 6.2 ± 1.0 0.038 
Family Coherence 5.4 ± 0.8 5.5 ± 0.7 0.287 
Family Support Index 5.6 ± 0.9 5.7 ± 0.8 0.134 
† Standard Deviation 
 
Table 4. Actor – Partner Interdependence Models^ 
 Dyads Triads 
Actor Effects Estimate p value Estimate p value 
YBCS     
irst-degree relationship* -.166 .364 .191 .226 
Age .001 .788 .011 .502 
Black Race* .285 .068 .014 .949 
Education .082 .053 -.073 .329 
Income -.010 .308 .008 .573 
Single relationship status -.159 .175 -.082 .724 
Lives alone -.103 .491 .101 .714 
Years since diagnosis* .040 .015 -.050 .031 
Anxiety -.198 .075 -.212 .250 





















Cost-related lack of access to care -.302 .007 -.395 .046 
Fear of recurrence* .048 .286 .025 .649 
Self-efficacy*  .288 <.001 .303 <.001 
Perceived Risk -.004 .857 -.004 .911 
     
Relatives     
First-degree relationship* .098 .572 .219 .092 
Age .001 .788 .001 .697 
Black Race* .419 .005 .424 .022 
Education .082 .053 .057 .171 
Income -.010 .308 .002 .807 
Single relationship status -.159 .175 -.087 .340 
Lives alone -.103 .491 .113 .408 
Years since diagnosis* -.002 .883 -.023 .224 
Anxiety -.198 .075 .119 .265 
Depression -.282 .014 -.025 .819 
Cost-related lack of access to care -.302 .007 -.225 .016 
Perceived risk .004 .857 -.026 .198 
     
Partner Effects†     
YBCS  Relative     
Age .007 .202 .032 .017 
Depression -.168 .148 -.369 .017 
Self-efficacy* .067 .309 .116 .047 
Relative  YBCS      
Income .010 .298 .019 .034 
Note:  Unstandardized estimates (B) and standard errors (SE) reported; ^ The dependent variable of the 
APIM analyses is the Family Support Index (PCA of the three scales); boldface indicates p<.05; † only 
significant (p<.05) partner effects in the triad data are reported along with the complementary nonsignificant 
results in the dyadic analysis; no significant (p<.05) partner effects were observed in dyadic data. *Dyad-
level predictors were degree type, race and years since diagnosis; fear of recurrence and self-efficacy were 
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Figure 1. Theoretical Framework 
 
Figure 2. Results of Actor-Partner Interdependence Models (APIM) of Family Support  
 
  


































Single relationship status 
Lives alone 
Clinical Characteristics 
Years since diagnosis* 
Anxiety 
Depression 
Family Support YBCS 
Family Communication 







Family Support in Illness 
Family Coherence 
Stressors 
Cost-related lack of access to care 
Fear of cancer recurrence* 
Perceived breast cancer risk 
Resources 
Self-efficacy breast cancer* 



























APIM of Family Support in YBCS and their biological Relatives  
YBCS: Young Breast Cancer Survivor; R: Relative 
Solid lines: actor effects 
Dashed lines: partner effects  
FSYBCS: Family Support in YBCS; FSR: Family Support in Relative 
AYBCS = YBCS actor effects; AR = Relative actor effects  
PYBCS-R = YBCS partner effects YBCS to Relative; PR-YBCS = partner effects Relative to YBCS  
Note: Statistically significant (p<.05) unstandardized coefficients for paths are displayed,  followed by standard 
errors in parentheses; *p<.05, **p<.01, ***p<.001. Baseline covariances and AR1  AR2 paths are not 
included in figures for simplicity as they are equivalent to AR1  AR1 and AR2  AR2 paths.  
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